FluidDA is active in the life sciences by developing tests to expedite drug development. The company uses simulation to help pharmaceutical companies determine the effectiveness of drugs early in the development process. Learn more in Taming the Cost of Respiratory Drug Development.
Luca Emili, CEO In Silico Trials, discusses the importance of using modern technologies like simulation to accelerate the FDA medical device and pharmaceutical approval process.
For more information read